UnitedHealth Group Inc. (UNH) filed a Form 4 reporting a routine ownership update for Christopher R. Zaetta, EVP & Chief Legal Officer. On 06/24/2025, Zaetta acquired 48.038 common shares at a stated price of $0, representing dividend-equivalent units credited on outstanding restricted stock units (RSUs). These dividend equivalents carry the same vesting conditions as the underlying RSUs and are forfeited if those units fail to vest. Following the credit, Zaetta’s direct beneficial ownership stands at 10,240.746 shares. No derivatives were reported, and there were no dispositions of shares.
UnitedHealth Group Inc. (UNH) – Form 4 filing, 26 Jun 2025: President & CFO John F. Rex reported an automatic acquisition of 131.931 common shares on 24 Jun 2025. The shares represent dividend-equivalent units credited on outstanding restricted stock units; no cash outlay was made (price = $0).
Following the credit, Rex directly owns 203,898.467 shares and indirectly owns 6,791 shares via a trust. No derivative transactions, open-market purchases, or sales were disclosed. The filing is routine and does not reflect a discretionary investment decision.
UnitedHealth Group Inc. (UNH) filed a Form 4 on 26-Jun-2025 detailing a minor insider transaction by Timothy J. Noel, Chief Executive Officer of UnitedHealthcare (a principal subsidiary).
On 24-Jun-2025, Noel acquired 47.823 shares of UNH common stock at $0.00 per share. The acquisition represents dividend-equivalent units automatically credited on outstanding restricted stock units (RSUs); these units carry the same vesting schedule as the underlying RSUs and will be forfeited if the RSUs do not vest. Following the credit, Noel’s direct beneficial ownership increased to 9,243.999 shares.
No open-market purchases, option exercises, or cash transactions occurred, and there was no use of a Rule 10b5-1 trading plan. The filing is procedural in nature, recording routine dividend accruals rather than an active investment decision by the insider.
UnitedHealth Group (UNH) – Form 4 insider transaction
Director Timothy P. Flynn reported the acquisition of 66 common shares on 06/24/2025. The shares represent dividend equivalents paid on previously vested deferred stock units and were received at $0 cost. After this transaction, Flynn’s holdings stand at 9,189 shares held directly and 6,033 shares held indirectly through a trust. The filing was submitted on 06/26/2025 by attorney-in-fact Faraz A. Choudhry.
UnitedHealth Group Inc. (UNH) Form 4 filing overview: Director Frederick William McNabb III reported the automatic acquisition of 53 shares of UnitedHealth common stock on 06/24/2025. The shares represent dividend-equivalent units paid on previously vested deferred stock units and were acquired at a stated price of $0.00 under the company’s equity plan.
Following the transaction, McNabb’s direct beneficial ownership increased to 13,709 shares. No derivative securities were bought or sold, and there were no dispositions. The filing was signed by attorney-in-fact Faraz A. Choudhry on 06/26/2025.
The transaction is routine, carries no cash outlay, and does not reflect an open-market purchase. It modestly increases the director’s equity alignment but is immaterial relative to UnitedHealth’s share count and market capitalization.
On 17 June 2025, UnitedHealth Group (UNH) executed an Underwriting and Pricing Agreement with BofA Securities, Barclays, Citigroup and J.P. Morgan to issue $3.0 billion of SEC-registered senior unsecured notes across four tranches: (i) $500 million 4.400% notes due 2028, (ii) $750 million 4.650% notes due 2031, (iii) $1.0 billion 5.300% notes due 2035 and (iv) $750 million 5.950% notes due 2055. The notes settled on 20 June 2025 under the company’s 2008 indenture with U.S. Bank Trust Company as trustee and were issued from automatic shelf registration statement 333-270279.
The 8-K is limited to filing transaction documents: underwriting & pricing agreements (Ex. 1.1-1.2), officers’ certificates & forms of notes (Ex. 4.1-4.4) and the Hogan Lovells legality opinion (Ex. 5.1). No changes to earnings guidance or strategy are disclosed. Proceeds are earmarked for general corporate purposes, providing additional liquidity while modestly increasing leverage and interest expense. By locking in fixed coupons out to 2055, UNH further staggers its maturity ladder at rates consistent with its large-cap investment-grade credit profile.